![Jinghua Pharmaceutical Group Co., Ltd. logo](/logos/002349.SZ.webp)
Jinghua Pharmaceutical Group Co., Ltd.
SZSE:002349.SZ
Overview | Financials
Company Name | Jinghua Pharmaceutical Group Co., Ltd. |
Symbol | 002349.SZ |
Currency | CNY |
Price | 8.74 |
Market Cap | 7,115,941,870 |
Dividend Yield | 1.03% |
52-week-range | 8.5 - 17.58 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yunzhong Zhou |
Website | https://www.jinghuapharm.com |
An error occurred while fetching data.
About Jinghua Pharmaceutical Group Co., Ltd.
Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD